Related Experiment Video
Updated: Jan 9, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Stress ulcer prophylaxis in non-critically ill patients: A cross-sectional survey in Saudi Arabia
Osamah M Alfayez1, Mashael AlFaifi2, Yara Ajeebi3
1Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia.
Abstract:
Stress ulcer prophylaxis (SUP) use is quite prevalent in the Saudi healthcare system in the general wards as reported by several studies. We aimed to assess the knowledge of physicians and their attitudes toward SUP prescription in non-critically ill patients in Saudi Arabia and identify factors associated with inappropriate SUP use. An electronic cross-sectional survey was administered to physicians registered with the Saudi Commission for Health Specialties. The questionnaire consisted of queries related to demographic information, SUP prescription patterns and frequency, preferred medications, and attitudes toward SUP. A total of 210 respondents completed the survey. Approximately half (48.1%) of the respondents reported prescribing SUP to non-critically ill patients, and 42.8% of respondents thought that their SUP use was supported by evidence. A fear of gastrointestinal (GI) bleeding and safety perceptions were major factors in SUP use. Clinical experience, medical rank, belief in evidence-based use of SUP, and fear of GI bleeding were all significantly correlated with SUP use (P <.05). Notably, 79% of respondents reported that they did not receive a pharmacist recommendation to stop therapy, and 38% said they would continue SUP upon discharge. This study presented the perspective of physicians regarding the main reasons for their use of SUP, along with factors significantly associated with this practice. Our findings indicate that there are opportunities to improve physician knowledge and empower interprofessional support to reduce inappropriate SUP use.
More Related Videos
05:50Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
06:20Contrast-Enhanced Subharmonic Aided Pressure Estimation SHAPE Using Ultrasound Imaging with a Focus on Identifying Portal Hypertension
Published on: December 5, 2020
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors